Lauge Farnaes

ORCID: 0000-0002-8569-4771
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Genomics and Rare Diseases
  • Infective Endocarditis Diagnosis and Management
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Infections and Vaccines
  • Cancer Genomics and Diagnostics
  • Pneumonia and Respiratory Infections
  • Cancer Treatment and Pharmacology
  • Genetic factors in colorectal cancer
  • Genomic variations and chromosomal abnormalities
  • Monoclonal and Polyclonal Antibodies Research
  • Genetics and Neurodevelopmental Disorders
  • COVID-19 epidemiological studies
  • Microbial Natural Products and Biosynthesis
  • Hematological disorders and diagnostics
  • Cytomegalovirus and herpesvirus research
  • SARS-CoV-2 and COVID-19 Research
  • Mycobacterium research and diagnosis
  • Antimicrobial Resistance in Staphylococcus
  • Metabolism and Genetic Disorders
  • Chemotherapy-related skin toxicity
  • Prenatal Screening and Diagnostics
  • Cystic Fibrosis Research Advances
  • Biosensors and Analytical Detection
  • Gut microbiota and health
  • Dysphagia Assessment and Management

University of California, San Diego
2011-2023

Rady Children's Hospital-San Diego
2018-2023

Children’s Institute
2017-2021

Office of Infectious Diseases
2021

The University of Kansas Health System
2015

University of California San Diego Medical Center
2015

Scripps Institution of Oceanography
2011-2013

Scripps Research Institute
2000-2005

Yale University
2000

Genetic diseases are leading causes of childhood mortality. Whole-genome sequencing (WGS) and whole-exome (WES) relatively new methods for diagnosing genetic diseases, whereas chromosomal microarray (CMA) is well established. Here we compared the diagnostic utility (rate causative, pathogenic, or likely pathogenic genotypes in known disease genes) clinical (proportion whom medical surgical management was changed by diagnosis) WGS, WES, CMA children with suspected systematic review literature...

10.1038/s41525-018-0053-8 article EN cc-by npj Genomic Medicine 2018-06-07

Abstract Genetic disorders are a leading cause of morbidity and mortality in infants. Rapid whole-genome sequencing (rWGS) can diagnose genetic time to change acute medical or surgical management (clinical utility) improve outcomes acutely ill We report retrospective cohort study inpatient infants regional children’s hospital from July 2016–March 2017. Forty-two families received rWGS for etiologic diagnosis disorders. Probands also standard testing as clinically indicated. Primary...

10.1038/s41525-018-0049-4 article EN cc-by npj Genomic Medicine 2018-03-29

Whole-genome sequencing (WGS) shows promise as a first-line genetic test for acutely ill infants, but widespread adoption and implementation requires evidence of an effect on clinical management.To determine the WGS management in racially ethnically diverse geographically distributed population infants US.This randomized, time-delayed trial enrolled participants from September 11, 2017, to April 30, 2019, with observation period extending July 2, 2019. The study was conducted at 5 US...

10.1001/jamapediatrics.2021.3496 article EN cc-by-nc-nd JAMA Pediatrics 2021-09-27

Genetic disorders are a leading contributor to mortality in the neonatal ICU and PICU United States. Although individually rare, there over 6,200 single-gene diseases, which may preclude genetic diagnosis prior admission. Rapid whole genome sequencing is an emerging method of diagnosing conditions time affect management neonates; however, its clinical utility has yet be adequately demonstrated critically ill children. This study evaluates next-generation pediatric critical care.Retrospective...

10.1097/pcc.0000000000002056 article EN Pediatric Critical Care Medicine 2019-07-01

Community-acquired pneumonia (CAP) is a common cause of pediatric hospital admission. Empiric antibiotic therapy for hospitalized children with serious CAP now targets the most likely pathogen(s), including those that may demonstrate significant resistance. Cell-free plasma next-generation sequencing (CFPNGS) was first made available Pediatric Infectious Diseases physicians in June 1, 2017, to supplement standard-of-care diagnostic techniques. A retrospective chart review performed between...

10.1016/j.diagmicrobio.2018.12.016 article EN cc-by-nc-nd Diagnostic Microbiology and Infectious Disease 2019-02-02

The diagnostic and clinical utility of rapid whole genome sequencing (rWGS) for critically ill children in the intensive care unit (ICU) has been substantiated by multiple studies, but comprehensive cost-effectiveness evaluation rWGS ICU outside neonatal age group is lacking. In this study, we examined cost data retrospectively a cohort 38 regional pediatric (PICU) who received rWGS. We identified seven 17 patients molecular diagnoses had resultant changes management with sufficient clarity...

10.3389/fped.2021.809536 article EN cc-by Frontiers in Pediatrics 2022-01-24

The microbial production, isolation, and structure elucidation of four new napyradiomycin congeners (1–4) is reported. structures these compounds, which are additions to the marine-derived meroterpenoids, were defined by comprehensive spectroscopic analysis X-ray crystallography. Using fluorescence-activated cell sorting (FACS) analysis, napyradiomycins 1–4 observed induce apoptosis in colon adenocarcinoma line HCT-116, indicating possibility a specific biochemical target for this class cytotoxins.

10.1021/np400466j article EN Journal of Natural Products 2013-12-13

Pediatric infective endocarditis incurs significant morbidity and generally occurs among children with underlying heart disease. Identification of a pathogen is critical in determining appropriate therapy. However, standard diagnostic testing has limited sensitivity. We describe case series whom plasma next-generation sequencing (Karius, Redwood, CA) identified an organism 8 10 cases.

10.1097/inf.0000000000003038 article EN The Pediatric Infectious Disease Journal 2020-12-30

Abstract Background Children affected by infectious diseases may not always have a detectable etiology. Diagnostic uncertainty can lead to prolonged hospitalizations, inappropriately broad or extended courses of antibiotics, invasive diagnostic procedures, and difficulty predicting the clinical course outcome. Cell-free plasma next-generation sequencing (cfNGS) identify viral, bacterial, fungal infections detecting pathogen DNA in peripheral blood. This testing modality offers ability test...

10.1186/s12879-021-06292-4 article EN cc-by BMC Infectious Diseases 2021-06-11

Osteoarticular infections (OAIs) are frequently encountered in children. Treatment may be guided by isolation of a pathogen; however, operative cultures often negative. Metagenomic next-generation sequencing (mNGS) allows for broad and sensitive pathogen detection that is culture-independent. We sought to evaluate the diagnostic utility mNGS comparison culture usual care testing detect pathogens acute osteomyelitis and/or septic arthritis children.This was single-site study use pediatric...

10.1093/ofid/ofab346 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-07-01

Pediatric central nervous system (CNS) infections are potentially life-threatening and may incur significant morbidity. Identifying a pathogen is important, both in terms of guiding therapeutic management characterizing prognosis. Usual care testing by culture polymerase chain reaction often unable to identify pathogen. We examined the systematic application metagenomic next-generation sequencing (mNGS) for detecting organisms transcriptomic analysis cerebrospinal fluid (CSF) children with...

10.1093/ofid/ofab104 article EN cc-by-nc-nd Open Forum Infectious Diseases 2021-03-06

An increasing number of studies suggest the importance antibodies in pathogenesis most systemic and organ-specific autoimmune diseases, although there is considerable controversy over precise role autoantibodies involved. In humans, a major obstacle to progress identification cloning relevant autoantigens. Here, an approach based on sequential use antibody phage display antigen expression libraries developed applied donor suffering from rheumatoid arthritis (RA), splenomegaly, peripheral...

10.1073/pnas.97.16.9234 article EN Proceedings of the National Academy of Sciences 2000-08-01

A 9-mo-old infant was admitted with infantile spasms that improved on administration of topiramate and steroids. He also had developmental delay, esotropia, hypsarrhythmia interictal electroencephalogram (EEG), normal brain magnetic resonance imaging (MRI). West syndrome is the triad spasms, hypsarrhythmia, mental retardation. Rapid trio whole-genome sequencing (WGS) revealed a novel, likely pathogenic, de novo variant in gene encoding γ-aminobutyric acid (GABA) type receptor, α1 polypeptide...

10.1101/mcs.a001776 article EN Molecular Case Studies 2017-05-11

There is an urgent need for new antibiotics to treat hospital- and community-associated methicillin-resistant Staphylococcus aureus (MRSA) infections. Previous work has indicated that both terrestrial marine-derived members of the napyradiomycin class possess potential anti-staphylococcal activities. These compounds are unique meroterpenoids with unusual levels halogenation. In this paper we report evaluation two previously described derivatives, A80915A (1) A80915B (2) produced by...

10.3390/md9040680 article EN cc-by Marine Drugs 2011-04-21

X-linked agammaglobulinemia (XLA, OMIM#300300) is a rare monogenic primary immunodeficiency caused by mutations in the Bruton tyrosine kinase (BTK) gene. XLA characterized insufficient immunoglobulin levels and susceptibility to life-threatening bacterial infections. We report on patient that presented with ecthyma gangrenosum septicemia. Rapid trio whole-genome sequencing (rWGS) revealed an apparently de novo hemizygous pathogenic variant (c.726dupT; p.Ile243TyrfsTer15) BTK Metagenomic...

10.1101/mcs.a003244 article EN Molecular Case Studies 2018-12-01
Coming Soon ...